$MRNA got hammered 23% today after leaked phase 3 cancer vaccine trial data came in weak. The stock had ripped higher months ago on positive early results, so this news basically gave back a chunk of those gains.
It touched -25% intraday before catching a small bounce off $180.60 support. I wasn't watching it live, but these kinds of intraday collapses can print serious profits if you catch them clean.
Already bounced $5 off the low, so I'm not chasing here. This could easily roll over and drop further tomorrow.
My buy level is $114 — the double gap window. If it doesn't come that low, I have zero interest. Above $258 is resistance, but I'd need to see the structure at the time before taking that trade.
No setup, no trade.
It touched -25% intraday before catching a small bounce off $180.60 support. I wasn't watching it live, but these kinds of intraday collapses can print serious profits if you catch them clean.
Already bounced $5 off the low, so I'm not chasing here. This could easily roll over and drop further tomorrow.
My buy level is $114 — the double gap window. If it doesn't come that low, I have zero interest. Above $258 is resistance, but I'd need to see the structure at the time before taking that trade.
No setup, no trade.